Ki67 is an independent predictor of oncological outcomes in patients with localized clear-cell renal cell carcinoma
Author:
Affiliation:
1. Department of Urology; University of Texas Southwestern Medical Center; Dallas TX USA
2. Department of Pathology; University of Texas Southwestern Medical Center; Dallas TX USA
Publisher
Wiley
Subject
Urology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.12263/fullpdf
Reference25 articles.
1. Correlation of Ki-67 and gelsolin expression to clinical outcome in renal clear cell carcinoma;Visapää;Urology,2003
2. Circulating biomarkers in advanced renal cell carcinoma: clinical applications;Hernandez-Yanez;Curr Oncol Rep,2012
3. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67;Gerdes;J Immunol,1984
4. Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluations in human malignancies;Gerdes;Semin Cancer Biol,1990
5. Ki-67 and coagulative tumor necrosis are independent predictors of poor outcome for patients with clear cell renal cell carcinoma and not surrogates for each other;Tollefson;Cancer,2007
Cited by 46 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Radiomics nomogram based on CT radiomics features and clinical factors for prediction of Ki-67 expression and prognosis in clear cell renal cell carcinoma: a two-center study;Cancer Imaging;2024-08-06
2. Assessment of Ki-67 proliferation index in prognosis prediction in patients with nonmetastatic clear cell renal cell carcinoma and tumor thrombus;Urologic Oncology: Seminars and Original Investigations;2024-01
3. Immunohistochemical expression of cytochrome P4A11 (CYP4A11), carbonic anhydrase 9 (CAIX) and Ki67 in renal cell carcinoma; diagnostic relevance and relations to clinicopathological parameters;Pathology - Research and Practice;2024-01
4. Radiomics and Ki-67 index predict survival in clear cell renal cell carcinoma;The British Journal of Radiology;2023-10
5. A nomogram incorporating Ki67 to predict survival of acral melanoma;Journal of Cancer Research and Clinical Oncology;2023-07-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3